Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others
Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others
Summary
GlobalData’s new report, “Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others” provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Summary
GlobalData’s new report, “Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others” provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the six market categories.
- Global corporate-level profiles of key companies operating within the United States Neurology Devicesmarket.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cyberonics, Inc., DePuy, Inc., Integra LifeSciences Holdings Corporation and others.
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United States Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Contents
1 TABLE OF CONTENTS1.1 List of Tables
1.2 List of Figures
2 INTRODUCTION
2.1 What is This Report About?
3 NEUROLOGY DEVICES IN UNITED STATES
3.1 Neurology Devices, Market Segmentation
3.2 Neurology Devices, United States, Overall Revenue ($m), 2003-2017
3.3 Neurology Devices Market, United States, Revenue Mix ($m), 2010
3.4 Neurology Devices Market, United States, Category Contribution (%), 2010
3.5 Neurology Devices, United States, Category Volume (Units), 2003-2017
3.6 Neurology Devices, United States, Company Share (2009-2010)
4 CSF MANAGEMENT IN UNITED STATES
4.1 CSF Management, Market Segmentation
4.2 CSF Management Market, United States, Revenue Mix ($m), 2010
4.3 CSF Management Market, United States, Segment Contribution (%), 2010
4.4 CSF Management Overall Revenue (2003-2017)
4.5 CSF Management Overall Volume (2003-2017)
4.6 CSF Management Average Price (2003-2017)
4.7 CSF Management Distribution Share (2009-2010)
4.8 CSF Management, United States, Company Share (2009-2010)
5 INTERVENTIONAL NEUROLOGY IN UNITED STATES
5.1 Interventional Neurology, Market.Segmentation
5.2 Interventional Neurology Market, United States, Revenue Mix ($m), 2010
5.3 Interventional Neurology Market, United States, Segment Contribution (%), 2010
5.4 Interventional Neurology Overall Revenue (2003-2017)
5.4.1 Embolic Systems Revenue 2003-2010
5.4.2 Navigational Systems Revenue 2003-2010
5.5 Interventional Neurology Overall Volume (2003-2017)
5.5.1 Embolic Systems Volume 2003-2010
5.5.2 Navigational Systems Volume (Units) 2003-2010
5.6 Interventional Neurology Average Price (2003-2017)
5.7 Interventional Neurology Distribution Share (2009-2010)
5.8 Interventional Neurology, United States, Company Share (2009-2010)
6 NEUROLOGICAL DIAGNOSTIC EQUIPMENT IN UNITED STATES
6.1 Neurological Diagnostic Equipment, Market.Segmentation
6.2 Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2010
6.3 Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2010
6.4 Neurological Diagnostic Equipment Overall Revenue (2003-2017)
6.5 Neurological Diagnostic Equipment Overall Volume (2003-2017)
6.6 Neurological Diagnostic Equipment Average Price (2003-2017)
6.7 Neurological Diagnostic Equipment Distribution Share (2009-2010)
6.8 Neurological Diagnostic Equipment, United States, Company Share (2009-2010)
7 NEUROSTIMULATION DEVICES IN UNITED STATES
7.1 Neurostimulation Devices, Market Segmentation
7.2 Neurostimulation Devices Market, United States, Revenue Mix ($m), 2010
7.3 Neurostimulation Devices Market, United States, Segment Contribution (%), 2010
7.4 Neurostimulation Devices Overall Revenue (2003-2017)
7.5 Neurostimulation Devices Overall Volume (2003-2017)
7.6 Neurostimulation Devices Average Price (2003-2017)
7.7 Neurostimulation Devices Distribution Share (2009-2010)
7.8 Neurostimulation Devices, United States, Company Share (2009-2010)
8 NEUROSURGICAL PRODUCTS IN UNITED STATES
8.1 Neurosurgical Products, Market Segmentation
8.2 Neurosurgical Products Market, United States, Revenue Mix ($m), 2010
8.3 Neurosurgical Products Market, United States, Segment Contribution (%), 2010
8.4 Neurosurgical Products Overall Revenue (2003-2017)
8.5 Neurosurgical Products Overall Volume (2003-2017)
8.6 Neurosurgical Products Average Price (2003-2017)
8.7 Neurosurgical Products Distribution Share (2009-2010)
8.8 Neurosurgical Products, United States, Company Share (2009-2010)
9 RADIOSURGERY IN UNITED STATES
9.1 Radiosurgery, Market Segmentation
9.2 Radiosurgery Market, United States, Revenue Mix ($m), 2010
9.3 Radiosurgery Market, United States, Segment Contribution (%), 2010
9.4 Radiosurgery Overall Revenue (2003-2017)
9.5 Radiosurgery Overall Volume (2003-2017)
9.6 Radiosurgery Average Price (2003-2017)
9.7 Radiosurgery Distribution Share (2009-2010)
9.8 Radiosurgery, United States, Company Share (2009-2010)
10 OVERVIEW OF KEY COMPANIES IN UNITED STATES NEUROLOGY DEVICES MARKET
10.1 Medtronic, Inc.
10.1.1 Company Overview
10.1.2 Share in the United States Neurology Devices Market
10.2 Boston Scientific Corporation
10.2.1 Company Overview
10.2.2 Share in the United States Neurology Devices Market
10.3 St. Jude Medical, Inc.
10.3.1 Company Overview
10.3.2 Share in the United States Neurology Devices Market
10.4 Cyberonics, Inc.
10.4.1 Company Overview
10.4.2 Share in the United States Neurology Devices Market
10.5 DePuy, Inc.
10.5.1 Company Overview
10.5.2 Share in the United States Neurology Devices Market
10.6 Integra LifeSciences Holdings Corporation
10.6.1 Company Overview
10.6.2 Share in the United States Neurology Devices Market
10.7 Terumo Corporation
10.7.1 Company Overview
10.8 Nihon Kohden Corporation
10.8.1 Company Overview
10.9 Elekta AB
10.9.1 Company Overview
10.10 Micrus Endovascular Corporation
10.10.1 Company Overview
10.11 Cadwell Laboratories, Inc.
10.11.1 Company Overview
10.12 ev3 Inc.
10.12.1 Company Overview
10.13 B. Braun Melsungen AG
10.13.1 Company Overview
10.14 Mizuho Ikakogyo Co., Ltd.
10.14.1 Company Overview
10.15 Accuray Incorporated
10.15.1 Company Overview
10.16 CareFusion Corporation
10.16.1 Company Overview
10.17 Natus Medical Incorporated
10.17.1 Company Overview
10.18 Covidien plc
10.18.1 Company Overview
10.19 Sophysa S.A.
10.19.1 Company Overview
10.20 KARL STORZ GmbH & Co. KG
10.20.1 Company Overview
11 NEUROLOGY DEVICES MARKET PIPELINE PRODUCTS
12 FINANCIAL DEALS LANDSCAPE
12.1 Acquisition
12.1.1 Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring
12.1.2 Boston Scientific Acquires Remaining Stake In Intelect Medical
12.1.3 Vycor Medical Completes Acquisition Of NovaVision
12.1.4 Synthes Acquires The Anspach Effort
12.1.5 Stryker Acquires Porex Surgical
12.1.6 Cardinal Health Sells 13.7% Stake In Carefusion
12.1.7 HealthMed Services Acquires Neural Communicator
12.1.8 Masimo Completes Acquisition Of SEDLine
12.1.9 Johnson & Johnson Completes Acquisition Of Micrus Endovascular
12.1.10 K-Kitz Acquires Bacterin In Reverse Acquisition
12.1.11 Medtronic Acquires Axon Systems
12.1.12 Covidien Completes Acquisition Of ev3 For $2.6 Billion
12.2 Partnerships
12.2.1 Boston Scientific Enters Into Partnership With Greatbatch Medical
12.2.2 Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions
12.2.3 EndoStim Enters Into an Agreement With Arizona State University
13 RECENT DEVELOPMENTS
13.1 Strategy and Business Planning
13.1.1 Jan 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes
13.1.2 Dec 17, 2010: Accuray Establishes Medical Affairs Function
13.1.3 Nov 09, 2010: Medtronic Opens New Distribution Center In Elizabeth, New Jersey
13.1.4 Nov 02, 2010: InVivo Therapeutics Opens New Manufacturing And Development Facility In Medford, Massachusetts
13.1.5 Oct 21, 2010: Collagen Matrix Expands Operations And Moves Corporate Headquarters To Oakland, New Jersey
13.1.6 Aug 26, 2010: Pico-Tesla Opens New Facility In Michigan
13.1.7 Aug 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection
13.1.8 Aug 20, 2010: Integra Opens Center For Research, Education And Training In Irvine, California
13.1.9 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO
13.1.10 Aug 10, 2010: CareFusion Announces Company-Wide Restructuring
13.1.11 Jun 02, 2010: B. Braun Announces Construction Of New Infusion Technology Facility In Melsungen, Germany
13.1.12 May 06, 2010: Swedish Cancer Institute And Elekta Renew Partnership Agreement
13.1.13 Apr 20, 2010: Siemens Opens National Customer Service Headquarters For 24x7 Service And Support
13.2 Legal and Regulatory
13.2.1 Jan 20, 2011: St. Jude Medical Reaches Settlement With DOJ
13.2.2 Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol
13.2.3 Dec 09, 2010: Medtronic Receives Subpoena From US Government For Certain Neurostimulation Devices
13.2.4 Nov 10, 2010: St. Jude Medical And AGA Medical Announce Early Termination Of HSR Waiting Period
13.2.5 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3
13.2.6 Sep 23, 2010: St. Jude Medical Faces Derivative Suit From Shareholders
13.2.7 Aug 10, 2010: Best Medical Files Patent Infringement Lawsuit Against Accuray
13.2.8 Jul 12, 2010: Law Offices Of Howard G. Smith Investigates Micrus Acquisition For Shareholders
13.2.9 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation
13.2.10 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3
13.2.11 Apr 09, 2010: Robbins Geller Files Class Action Suit Against Boston Scientific
13.3 Government and Public Interest
13.3.1 Feb 16, 2011: University Of Minnesota Researchers Receive $3m Grants To Create Robotic Devices And Computer Vision Algorithms For Early Detection Of Childhood Mental Disorders
13.3.2 Feb 15, 2011: Mayo Clinic Researchers Develop WINCS Device To Measure Brain Chemistry During Deep Brain Stimulation
13.3.3 Jan 24, 2011: Deep Brain Stimulation May Help Hard-To-Control High Blood Pressure: Case Study
13.3.4 Jan 18, 2011: Stents Help Stroke Victims When Other Treatments Fails: Research At ISET
13.3.5 Dec 21, 2010: Boston Scientific Receives Notices Of Deficiency From IRS
13.3.6 Dec 16, 2010: Researchers Suggest Diagnostic Criteria For Posttraumatic Stress Disorder Are Lacking
13.3.7 Nov 29, 2010: Neuro Kinetics Earns Approval From Health Canada To Sell Diagnostic Devices In Canada
13.3.8 Nov 14, 2010: Mental Introspection Increases As Brain Areas Begin To Act In Sync: Georgetown University Medical Center
13.3.9 Oct 25, 2010: Radiation Therapy Improves Painful Condition Associated With MS: ASTRO
13.3.10 Oct 08, 2010: Senator Grassley Questions VA Official's Relationship With Medtronic
13.3.11 Oct 06, 2010: Salk Researchers Map Functional Connections Between Retinal Neurons At Single-Cell Resolution
13.3.12 Sep 24, 2010: Scarless Brain Surgery Is New Option For Patients: UCSD And University Of Washington Study
13.3.13 Sep 14, 2010: FDA Advisory Committee To Discuss Clinical Trial Design Issues For Neurological Devices
13.3.14 Sep 08, 2010: SMU-Led Research Center Aims To Connect Brain Signals To Robotic Limbs
13.3.15 Aug 25, 2010: Research Heralds Potential For Early Diagnosis Of Degenerative Brain Disorders
13.3.16 Aug 22, 2010: Gene Scan Finds Link Across Array Of Childhood Brain Disorders
13.3.17 Aug 11, 2010: Boston Scientific Resolves Corporate Warning Letter
13.3.18 Jul 22, 2010: Stanford University School Of Medicine Seeks Patient Enrollment For Alzheimer's Study
13.3.19 Jul 12, 2010: MRI Better Than CT Scans At Diagnosing Stroke: New Guideline
13.3.20 Jun 30, 2010: New Study Identifies Best Tests For Predicting Alzheimer’s Disease: Study
13.3.21 Jun 22, 2010: UCLA Brain Scanning Study Has Implications For Advertising, Public Health Campaigns
13.3.22 Jun 03, 2010: Governor Designates Cleveland Health And Technology Corridor An Ohio Hub Of Innovation And Opportunity
13.3.23 May 11, 2010: Stereotactic Radiosurgery Is Safe And Effective For Selected Children With Arteriovenous Malformations: Mayo Clinic
13.3.24 May 04, 2010: Stereotactic Radiosurgery Successful For Most Patients With Large Acoustic Neuromas: Mayo Clinic
13.3.25 May 03, 2010: Imaging Study Discovers Brain Development Differences In Kids With Fragile X Syndrome: Study
13.3.26 Apr 30, 2010: Tiny Particles May Help Surgeons By Marking Brain Tumors
13.3.27 Apr 19, 2010: Surgeons Use Brain Port Device To Treat Brain Cyst
13.3.28 Apr 18, 2010: Scientists Develop Brain-Recording Device To Control Seizures
13.3.29 Apr 16, 2010: Clinical Study Shows Patients Gain Limb Movement Years After Stroke
13.3.30 Apr 09, 2010: CDRH: Research Needed To Explore Side Effects Of Pediatric Devices
13.3.31 Apr 01, 2010: UC Researchers Quantify Benefits Of Minimally Invasive Removal For Tumors
13.4 Product News
13.4.1 Aug 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference
13.4.2 Jul 15, 2010: Elekta To Highlight Intelligent Cancer Management Solutions At 2010 AAPM Annual Meeting
13.4.3 May 05, 2010: Terumo Announces Its Program For The Global Embolization Symposium And Technologies (GEST) Meeting
14 APPENDIX
14.1 Definitions of Markets Covered in the Report
14.1.1 Neurology Devices
14.2 Research Methodology
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Forecasts
14.7 Expert Panels
14.8 GlobalData Consulting
14.9 Currency Conversion
14.10 Contact Us
14.11 Disclaimer
LIST OF TABLES
Table 1: Neurology Devices, United States, Overall Revenue ($m), 2003-2017
Table 2: Neurology Devices Market, United States, Category Contribution (%), 2010
Table 3: Neurology Devices, United States, Cross-Category Analysis, 2003-2017
Table 4: Neurology Devices, United States, Overall Revenue ($m), Historic, 2003-2010
Table 5: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017
Table 6: Neurology Devices, United States, Category Volume (Units), 2003-2017
Table 7: Neurology Devices, United States, Category Volume (Units), Historic, 2003-2010
Table 8: Neurology Devices, United States, Category Volume (Units), Forecast, 2010-2017
Table 9: Neurology Devices, United States, Company Share by Revenue ($m), 2009-2010
Table 10: CSF Management Market, United States, Segment Contribution (%), 2010
Table 11: CSF Management, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 12: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 13: CSF Management, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 14: CSF Management, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 15: CSF Management, United States, Average Price ($), Historic, 2003-2010
Table 16: CSF Management, United States, Average Price ($), Forecast, 2010-2017
Table 17: CSF Management, United States, Distribution Share by Revenue ($m), 2009-2010
Table 18: CSF Management, United States, Company Share by Revenue ($m), 2009-2010
Table 19: Interventional Neurology Market, United States, Segment Contribution (%), 2010
Table 20: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 21: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 22: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 23: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 24: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Table 25: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Table 26: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 27: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 32: Interventional Neurology, United States, Average Price ($), Historic, 2003-2010
Table 33: Interventional Neurology, United States, Average Price ($), Forecast, 2010-2017
Table 34: Interventional Neurology, United States, Distribution Share by Revenue ($m), 2009-2010
Table 35: Interventional Neurology, United States, Company Share by Revenue ($m), 2009-2010
Table 36: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2010
Table 37: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 38: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 39: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 40: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 41: Neurological Diagnostic Equipment, United States, Average Price ($), Historic, 2003-2010
Table 42: Neurological Diagnostic Equipment, United States, Average Price ($), Forecast, 2010-2017
Table 43: Neurological Diagnostic Equipment, United States, Distribution Share by Revenue ($m), 2009-2010
Table 44: Neurological Diagnostic Equipment, United States, Company Share by Revenue ($m), 2009-2010
Table 45: Neurostimulation Devices Market, United States, Segment Contribution (%), 2010
Table 46: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 47: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 48: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 49: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 50: Neurostimulation Devices, United States, Average Price ($), Historic, 2003-2010
Table 51: Neurostimulation Devices, United States, Average Price ($), Forecast, 2010-2017
Table 52: Neurostimulation Devices, United States, Distribution Share by Revenue ($m), 2009-2010
Table 53: Neurostimulation Devices, United States, Company Share by Revenue ($m), 2009-2010
Table 54: Neurosurgical Products Market, United States, Segment Contribution (%), 2010
Table 55: Neurosurgical Products, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 56: Neurosurgical Products, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 57: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 58: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 59: Neurosurgical Products, United States, Average Price ($), Historic, 2003-2010
Table 60: Neurosurgical Products, United States, Average Price ($), Forecast, 2010-2017
Table 61: Neurosurgical Products, United States, Distribution Share by Revenue ($m), 2009-2010
Table 62: Neurosurgical Products, United States, Company Share by Revenue ($m), 2009-2010
Table 63: Radiosurgery Market, United States, Segment Contribution (%), 2010
Table 64: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2003-2010
Table 65: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Table 66: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2003-2010
Table 67: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2010-2017
Table 68: Radiosurgery, United States, Average Price ($), Historic, 2003-2010
Table 69: Radiosurgery, United States, Average Price ($), Forecast, 2010-2017
Table 70: Radiosurgery, United States, Distribution Share by Revenue ($m), 2009-2010
Table 71: Radiosurgery, United States, Company Share by Revenue ($m), 2009-2010
Table 72: Neurology Devices Market Pipeline Products
Table 73: Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring
Table 74: Boston Scientific Acquires Remaining Stake In Intelect Medical
Table 75: Vycor Medical Completes Acquisition Of NovaVision
Table 76: Synthes Acquires The Anspach Effort
Table 77: Stryker Acquires Porex Surgical
Table 78: Cardinal Health Sells 13.7% Stake In Carefusion
Table 79: HealthMed Services Acquires Neural Communicator
Table 80: Masimo Completes Acquisition Of SEDLine
Table 81: Johnson & Johnson Completes Acquisition Of Micrus Endovascular
Table 82: K-Kitz Acquires Bacterin In Reverse Acquisition
Table 83: Medtronic Acquires Axon Systems
Table 84: Covidien Completes Acquisition Of ev3 For $2.6 Billion
Table 85: Boston Scientific Enters Into Partnership With Greatbatch Medical
Table 86: Synergetics USA Enters Into Co-Development Agreement With Retinal Solutions
Table 87: EndoStim Enters Into An Agreement With Arizona State University
Table 88: USD to Local Currency, United States, Average Actual Rate 2003-2010
LIST OF FIGURES
Figure 1: Neurology Devices, Market Segmentation
Figure 2: Neurology Devices, United States, Overall Revenue ($m), 2003-2017
Figure 3: Neurology Devices Market, United States, Revenue Mix ($m), 2010
Figure 4: Neurology Devices Market, United States, Category Contribution (%), 2010
Figure 5: Neurology Devices, United States, Cross-Category Analysis, 2003-2017
Figure 6: Neurology Devices, United States, Overall Revenue ($m), Historic, 2003-2010
Figure 7: Neurology Devices, United States, Overall Revenue ($m), Forecast, 2010-2017
Figure 8: Neurology Devices, United States, Category Volume (Units), 2003-2017
Figure 9: Neurology Devices, United States, Category Volume (Units), Historic, 2003-2010
Figure 10: Neurology Devices, United States, Category Volume (Units), Forecast, 2010-2017
Figure 11: Neurology Devices, United States, Company Share (%), 2010
Figure 12: CSF Management, Market Segmentation
Figure 13: CSF Management Market, United States, Revenue Mix ($m), 2010
Figure 14: CSF Management Market, United States, Segment Contribution (%), 2010
Figure 15: CSF Management, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 16: CSF Management, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 17: CSF Management, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 18: CSF Management, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 19: CSF Management, United States, Company Share (%), 2010
Figure 20: Interventional Neurology, Market Segmentation
Figure 21: Interventional Neurology Market, United States, Revenue Mix ($m), 2010
Figure 22: Interventional Neurology Market, United States, Segment Contribution (%), 2010
Figure 23: Interventional Neurology, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 24: Interventional Neurology, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 25: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 26: Embolic Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 27: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010
Figure 28: Navigational Systems, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
Figure 29: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 30: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 31: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 32: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 33: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 34: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 35: Interventional Neurology, United States, Company Share (%), 2010
Figure 36: Neurological Diagnostic Equipment, Market Segmentation
Figure 37: Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2010
Figure 38: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2010
Figure 39: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 40: Neurological Diagnostic Equipment, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 41: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 42: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 43: Neurological Diagnostic Equipment, United States, Company Share (%), 2010
Figure 44: Neurostimulation Devices, Market Segmentation
Figure 45: Neurostimulation Devices Market, United States, Revenue Mix ($m), 2010
Figure 46: Neurostimulation Devices Market, United States, Segment Contribution (%), 2010
Figure 47: Neurostimulation Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 48: Neurostimulation Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 49: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 50: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 51: Neurostimulation Devices, United States, Company Share (%), 2010
Figure 52: Neurosurgical Products, Market Segmentation
Figure 53: Neurosurgical Products Market, United States, Revenue Mix ($m), 2010
Figure 54: Neurosurgical Products Market, United States, Segment Contribution (%), 2010
Figure 55: Neurosurgical Products, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 56: Neurosurgical Products, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 57: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 58: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 59: Neurosurgical Products, United States, Company Share (%), 2010
Figure 60: Radiosurgery, Market Segmentation
Figure 61: Radiosurgery Market, United States, Revenue Mix ($m), 2010
Figure 62: Radiosurgery Market, United States, Segment Contribution (%), 2010
Figure 63: Radiosurgery, United States, Revenue ($m) by Segment, Historic, 2003-2010
Figure 64: Radiosurgery, United States, Revenue ($m) by Segment, Forecast, 2010-2017
Figure 65: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2003-2010
Figure 66: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2010-2017
Figure 67: Radiosurgery, United States, Company Share (%), 2010
Figure 68: Medtronic, Inc., Company Share (%),United States Neurology Devices Market, 2010
Figure 69: Boston Scientific Corporation, Company Share (%),United States Neurology Devices Market, 2010
Figure 70: St. Jude Medical, Inc., Company Share (%),United States Neurology Devices Market, 2010
Figure 71: Cyberonics, Inc., Company Share (%),United States Neurology Devices Market, 2010
Figure 72: DePuy, Inc., Company Share (%),United States Neurology Devices Market, 2010
Figure 73: Integra LifeSciences Holdings Corporation, Company Share (%),United States Neurology Devices Market, 2010
Skip to top